HC Wainwright & Co. Maintains Buy on Liquidia, Raises Price Target to $65
10/15/2026
Impact: 75
Healthcare
HC Wainwright & Co. analyst Andrew S. Fein has maintained a 'Buy' rating on Liquidia (NASDAQ: LQDA) and increased the price target from $58 to $65.
AI summary, not financial advice
Share: